发明名称 |
Uses of interleukin-22(IL-22) in treating and preventing nerve damage diseases or neurodegenerative diseases |
摘要 |
This invention discloses the uses of IL-22 in the treatment and prevention of a nerve damage disease or a neurodegenerative disease. In particular, the invention discloses the uses of IL-22 or IL-22 dimers as follows: (i) can protect neurons to recover the functions of injured neurons after ischemic nerve damage in animals in vivo, thus enabling effective treatment of nerve damage diseases, (ii) can significantly inhibit the loss of dopaminergic neurons in substantia nigra in PD model animal, enhance the functions of dopaminergic neurons, significantly reduce neuronal apoptosis in hippocampus, improve learning and memory capacity of AD model rats, and effectively prevent neuronal loss, thereby enabling more effective treatment of neurodegenerative diseases. |
申请公布号 |
US9352024(B2) |
申请公布日期 |
2016.05.31 |
申请号 |
US201214369187 |
申请日期 |
2012.12.27 |
申请人 |
Generon (Shanghai) Corporation LTD. |
发明人 |
Wu Dongdong;Huang Zhihua;Liu Heng;Huang Yuliang;Yan Xiaoqiang |
分类号 |
A61K38/20;A61K47/48 |
主分类号 |
A61K38/20 |
代理机构 |
Morrison & Foerster LLP |
代理人 |
Morrison & Foerster LLP |
主权项 |
1. A method of treating or preventing Parkinson's disease, or treating stroke in a subject, comprising administering to the subject an effective amount of an IL-22 or a dimer or multimer thereof. |
地址 |
Shanghai CN |